Issue 6/2022

Expression of Tmem41b and MMP13 associated with poor outcome in osteosarcomas

Guo-Hua Li, Xiao Liu, Lin-Jie Feng,  Liu Zhang

DOI: 10.4149/neo_2021_201209N1329

Osteopontin and its downstream carcinogenic molecules: regulatory mechanisms and prognostic value in cancer progression (1253 — 1269)

Lang Chen, Xuan Huan, Guo-Hui Xiao, Wu-Han Yu, Teng-Fei Li, Xi-Dan Gao,  You-Cheng Zhang

DOI: 10.4149/neo_2022_220507N489

The role of SPDEF in cancer: promoter or suppressor (1270 — 1276)

Ke-Chun Bao,  Fen-Fen Wang

DOI: 10.4149/neo_2022_220529N571

Cancer-associated fibroblasts subtypes and role in invasion and metastasis of gastric cancer (1277 — 1288)

Meng Zhang, Wen-Bin Guan, Jun-Lei Li, Ling-Xuan Li, Ke-Zhou Wang,  Rui-Fen Wang,  Li-Feng Wang

DOI: 10.4149/neo_2022_220513N511

Differences in tolerogenic status of NK cells between luminal A type, luminal B type, and triple-negative breast cancer (1289 — 1302)

Alma Starčević, Damir Grebić, Manuela Avirović, Martina Mavrinac, Petra Valković Zujić, Danijela Veljković Vujaklija,  Tamara Gulić

DOI: 10.4149/neo_2022_220615N635

HOXC10 indicates poor survival outcome in gastric cancer and promotes G1/S cell cycle transition through transcriptional repression of p21 (1303 — 1313)

Zheng-Hua Lin, Jia-Min He, San-Chuan Lai, Ning Ding, Ying Jiang, Xing-Kang He, Xiao-Sun Liu,  Zhi-Hui Huang

DOI: 10.4149/neo_2022_220609N615

Mutational landscape of DNA damage response deficiency-related genes and its association with immune biomarkers in esophageal squamous cell carcinoma (1314 — 1321)

Gang Chen, Yong-Jun Zhu, Ji Chen, Feng Miao, Ning Wu, Yang Song, Bei-Bei Mao, Sheng-Zhou Wang,  Fei Xu,  Zhi-Ming Chen

DOI: 10.4149/neo_2022_220721N738

Functions of long non-coding RNA LNC11649 in non-small cell lung cancer cells as a reprocessed form of MALAT1 (1322 — 1337)

Jun-Zhe Qi, Ting-Ting Zhao,  Shu-Shan Qi

DOI: 10.4149/neo_2022_220705N689

PRKAA1, stabilized by FTO in an m6A-YTHDF2-dependent manner, promotes cell proliferation and glycolysis of gastric cancer by regulating the redox balance (1338 — 1348)

Yangmei Zhang, Xichang Zhou, Xue Cheng, Xiou Hong, Xiaowei Jiang, Guilong Jing,  Kai Chen,  Yang Li

DOI: 10.4149/neo_2022_220714N714

PHF21A expression as a biomarker of hepatocellular carcinoma progression and prognosis (1349 — 1358)

Jia-Qing Huang, Li-Chen Ji, Qiang-An Jing, Yi-Chen He,  Ying-Yu Ma,  Xiang-Min Tong

DOI: 10.4149/neo_2022_220807N806

miR-550a-5p promotes the proliferation and migration of hepatocellular carcinoma by targeting GNE via the Wnt/β-catenin signaling pathway (1359 — 1372)

Chun-Ming Li, Wu Wu, Zhu Zhu, Pei-Lin Lu, Jian-Ping Gong,  Rong Ma

DOI: 10.4149/neo_2022_220727N774

SUMO1-modified DNA methyltransferase 1 induces DNA hypermethylation of VWC2 in the development of colorectal cancer (1373 — 1385)

Xiao-Hu Cheng, Tong-Tong Xu, Lian-Bang Zhou, Fang-Yuan Li, Song Wang, Huan-Ru Liang, Jing-Jing Tang, Chang-Qin Duan, Heng Jiang, Ying-Feng Zhang,  Zhi-Ning Liu

DOI: 10.4149/neo_2022_220817N841

GDF11 knockdown downregulates SMURF1 to inhibit breast cancer progression by activation of p53 and inactivation of ERα signaling (1386 — 1395)

Hai-Li Tang, Qi Wang, Jian-Guo Lu, Xiao-Jun Yang, Jiao-Jiao Shi, Sheng-Peng Wang, Chang-Qing Cao,  Hua-Dong Zhao

DOI: 10.4149/neo_2022_220607N601

Stanniocalcin1 knockdown induces ferroptosis and suppresses glycolysis in prostate cancer via the Nrf2 pathway (1396 — 1405)

Yuan-Qing Dai, Yao Bai, Jie Gu,  Ben-Yi Fan

DOI: 10.4149/neo_2022_220626N665

LncRNA CBR3-AS1 predicts a poor prognosis and promotes cervical cancer progression through the miR-3163/LASP1 pathway (1406 — 1417)

Yipin Cai, Yu Huang, Jie Zhang, Xiaoli Liu, Fang Zhao, Kuan Zhang, Songyuan Xu, Yan Yang,  Haiwei Huang,  Yu Gao

DOI: 10.4149/neo_2022_220730N784

TLR2 and TLR4 in colorectal cancer: relationship to tumor necrosis and markers of systemic inflammation (1418 — 1424)

 Karoliina Paarnio, Juha Väyrynen, Sara Väyrynen, Tiina Kantola, Timo Karhu, Taina Tervahartiala, Kai Klintrup, Timo Sorsa, Tuula Salo, Jyrki Mäkelä, Tuomo Karttunen

DOI: 10.4149/neo_2022_220509N498

Moderately hypofractionated salvage radiotherapy in patients with biochemical recurrence of prostate cancer after prostatectomy: long-term results and comparative analysis of two schedules (1425 — 1436)

 Fabio Matrone, Alessandra Donofrio, Giuseppe Fanetti, Alberto Revelant, Jerry Polesel, Paola Chiovati, Roberto Bortolus

DOI: 10.4149/neo_2022_220825N864

The prognostic impact of immune checkpoint inhibitors for the treatment of pulmonary sarcomatoid carcinoma: A multicenter retrospective study (1437 — 1444)

Jing-Wen Wei, Yue Hao, Jing Xiang, Xing-Xiang Pu, Li-Ping Wang, Zhan-Sheng Jiang, Jing-Xun Wu, Qian Wang, Chun-Wei Xu, Wen-Xian Wang,  Zheng-Bo Song

DOI: 10.4149/neo_2022_220617N644

Safety and efficacy of the FLOT regimen in the Polish population - an analysis of the prospective trial (1445 — 1450)

 Katarzyna Marcisz-Grzanka, Mariola Winiarek, Jakub Pałucki, Paulina Wieszczy, Tomasz Olesiński, Mariusz Jóźwiak, Radosław Samsel, Urszula Sułkowska, Agnieszka Kolasińska-Ćwikła,  Lucjan Wyrwicz

DOI: 10.4149/neo_2022_220720N734

Evaluation of serum glucose-regulated protein 78 (GRP78) as a biomarker of treatment response to bortezomib-based induction regimen in multiple myeloma: A cross-sectional pilot study (1451 — 1458)

Suganthi Ramachandran,  Pooja Gupta, Lalit Kumar, Ritu Gupta, Lavisha Goel, Vijay Kumar, Yogendra Gupta

DOI: 10.4149/neo_2022_220526N564

Correlation between gastritis cystica profunda and the risk of lymph node metastasis in early gastric cancer (1459 — 1465)

Jia-Jia Wu, Yu-Qing Cheng, Hao-Jun Yang,  Min Lin

DOI: 10.4149/neo_2022_220314N281

Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index (1466 — 1473)

 Alice Sýkorová, Vít Procházka, Heidi Móciková, Andrea Janíková, Robert Pytlík, David Belada, Kateřina Benešová, Pavel Klener, Juraj Ďuraš, Lukáš Smolej, Vít Campr, Petra Blahovcová, Marek Trněný

DOI: 10.4149/neo_2022_221030N1064

Real-world evidence of efficacy and safety of pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: Czech registry data (1474 — 1479)

 Viera Sandecka, Luděk Pour, Ivan Špička, Jiří Minařík, Jakub Radocha, Tomáš Jelínek, Petr Pavlíček, Alexandra Jungová, Petr Kessler, Marek Wróbel, Martin Štork, Jan Štraub, Tomáš Pika, Lenka Čápková, Sabina Ševčíková, Vladimír Maisnar, Roman Hájek

DOI: 10.4149/neo_2022_220813N827

Clinical characteristics and prognostic value of EGFR mutation in stage I lung adenocarcinoma with spread through air spaces after surgical resection (1480 — 1489)

Mao-Gang Gao, Shi-Ze Wang, Kai-Hong Han,  Shao-Nan Xie,  Qing-Yi Liu

DOI: 10.4149/neo_2022_220619N649

Mast cells as a tumor microenvironment factor associated with the aggressiveness of prostate cancer (1490 — 1498)

 Taras Zadvornyi,  Natalia Lukianova,  Tetiana Borikun, Andrii Tymoshenko, Oleksandr Mushii, Olena Voronina, Iurii Vitruk, Eduard Stakhovskyi, Vasyl Chekhun

DOI: 10.4149/neo_2022_221014N1020